Description
SITAJAN MET 50/500 TABLET combines two highly effective antidiabetic agents:
Sitagliptin Phosphate – 50 mg
Metformin Hydrochloride – 500 mg
This dual-therapy formulation is designed for adults with Type 2 Diabetes Mellitus who require a combination approach to manage high blood glucose levels, especially when monotherapy alone proves insufficient.
Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body’s natural ability to regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals.
Metformin is a first-line biguanide oral agent that reduces hepatic glucose production and improves insulin sensitivity.
Together, these agents act synergistically to regulate both fasting and postprandial blood sugar levels, improve HbA1c, and reduce the progression of complications related to diabetes.
Type 2 Diabetes Mellitus
Patients inadequately controlled on Metformin or Sitagliptin monotherapy
Second-line therapy when diet, exercise, and monotherapy are insufficient
Dual mechanism of action for optimal glycemic control
Improves insulin sensitivity and secretion in a glucose-dependent manner
Lower risk of hypoglycemia compared to sulfonylureas
Proven to reduce HbA1c levels effectively
Helps in long-term management of diabetes-related complications
Sitagliptin – DPP-4 inhibitor
Metformin – Biguanide antidiabetic
Film-coated tablet for easy administration
Well-tolerated with a low risk of weight gain
Manufactured in WHO-GMP, ISO-certified facilities
Full regulatory and quality documentation available
BLUEPILL EXPRESS is a renowned third-party pharmaceutical manufacturer and global exporter of medicines. We supply high-quality, affordable, and regulatory-compliant products across Asia, Africa, CIS, Latin America, Middle East, and Europe.
Our expertise includes:
Regulatory documentation (COA, MSDS, Stability Data)
Custom branding and private label manufacturing
Secure and timely global logistics
Dedicated support for large-scale pharma buyers and distributors
To be taken orally with meals to reduce gastrointestinal side effects
Dose to be determined by the physician based on individual blood glucose levels
Not suitable for Type 1 diabetes or diabetic ketoacidosis
Regular monitoring of kidney function is recommended
